The Union and RESIST-TB invite you to join an exciting webinar on Thursday, June 7th from 08:00 – 09:00 EST (14:00 – 15:00 CET and SAST) to review the results of the 2017-2018 DR-TB Working Group Survey regarding the global rollout of the 9-month TB regimen and the use of bedaquiline and delamanid for MDR-TB treatment. This discussion will cover the results of the 2018 survey, compare these to the results of the 2017 survey, and explore the current barriers to progress related to the rollout of these regimens. Please join DR-TB WG Co-Chairs Robert Horsburgh, Chen-Yuen Chiang, and Arnaud Trebucq to hear about global progress in implementing these regimens.
Please read the below information on how to register to receive connection details for this webinar.
To join the event as an attendee
1. Go to https://attendee.gotowebinar.com/register/5471390152498883843
2. Fill out the required fields and click the “Register” button at the bottom of the page.NOTE: If you are member of the Union, please enter your CU- membership ID in the designated field. If you are NOT a member of the Union, please leave this field blank. For future Union presentations, registration will require Union membership.
After you have registered for the event, you will receive a follow-up email from the Union with the link and instructions to join the webinar.
To contact your host, RESIST-TB, please send a message to email@example.com.
IMPORTANT NOTICE: This WebEx service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this session, you automatically consent to such recordings. If you do not consent to the recording, discuss your concerns with the meeting host prior to the start of the recording or do not join the session. Please note that any such recordings may be subject to discovery in the event of litigation.